S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern

Enanta Pharmaceuticals (ENTA) SEC Filings & 10K Form

$16.45
-0.30 (-1.79%)
(As of 04/12/2024 08:51 PM ET)

Recent Enanta Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/08/2024
4:23 PM
Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:27 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:30 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:15 PM
Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:19 PM
Enanta Pharmaceuticals (Issuer)
Hata Yujiro S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:12 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:31 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:11 PM
Enanta Pharmaceuticals (Subject)
Krensavage Asset Management, LLC (Filed by)
Form SCHEDULE 13G
02/14/2024
7:21 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:23 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:00 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:09 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:12 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:15 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:18 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
11:15 PM
Enanta Pharmaceuticals (Filer)
Form EFFECT
01/26/2024
8:11 AM
Enanta Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
01/24/2024
4:23 PM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/22/2024
11:25 AM
Enanta Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/11/2024
3:15 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
12/15/2023
7:08 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:16 PM
Enanta Pharmaceuticals (Subject)
Vance Terry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
7:26 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:29 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:31 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:17 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:19 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:22 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:24 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:24 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:08 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:11 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:15 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:19 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:21 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:10 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:10 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:11 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:11 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Buy Alert (Ad)

Imagine knowing, ahead of time, what the best investments of the year would be… Well, investors no longer need to imagine, guess, or throw darts. See, we’ve uncovered what looks to be a list of THE 10 best opportunities for 2024.

Click here for your FREE report: 10 Great Stocks Under $10
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:38 PM
Enanta Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/22/2023
3:12 PM
Enanta Pharmaceuticals (Filer)
Form POSASR
11/22/2023
3:21 PM
Enanta Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/16/2023
3:31 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
10/06/2023
1:34 PM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
06/07/2023
6:01 AM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2023
6:25 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ENTA) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners